2007-2010四年间鲍曼不动杆菌耐药性变迁及对亚胺培南耐药的机制研究

目的研究2007-2010四年间中山大学附属第一医院临床分离的鲍曼不动杆菌的耐药性迁移情况和耐亚胺培南的鲍曼不动杆菌(IRAB)的耐药机制,为临床抗感染治疗提供依据。方法采用VITEK 2型全自动微生物检测系统对细菌进行鉴定及药敏分析;用PCR方法检测碳青霉烯酶基因blaOXA-51、blaOXA-23、blaOXA-24和blaOXA-58。结果 2007-2010四年间分离鲍曼不动杆菌811株,耐药率逐年上升,其对头孢哌酮/舒巴坦、美罗培南、头孢吡肟、亚胺培南和哌拉西林/他唑巴坦的耐药率上升明显,如对亚胺培南的耐药率自2007-2010年分别为13.1%、26.0%、44.3%和59.5%。811株鲍曼不动杆菌中IRAB有311株,IRAB对抗生素的耐药率明显升高,但四年间的耐药率变化并不明显。对IRAB敏感的抗生素以阿米卡星为首,其次为头孢哌酮/舒巴坦,但头孢哌酮/舒巴坦的敏感率逐年下降。从311株IRAB中随机抽取140株,检出blaOXA-51基因阳性125株(89.3%),blaOXA-23基因阳性29株(20.7%),blaOXA-24基因阳性3株(2.14%),blaOXA-58基因阳性22株(15.7%)。结论鲍曼不动杆菌的耐药性逐年升高,以阿米卡星与头孢哌酮/舒巴坦联合应用为有效的治疗方法,产碳青霉烯酶是IRAB的主要耐药机制。     

Trans‐3,5,4´‐trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl‐2 pathway by upregulation of miR‐345 and miR‐498

Despite initial dramatic efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (EGFR‐TKIs) in EGFR‐mutant lung cancer patients, subsequent emergence of acquired resistance is almost inevitable. Resveratrol and its derivatives have been found to exert some effects on EGFR‐TKI resistance in non‐small cell lung cancer (NSCLC), but the underlying mechanisms remain unclear. We screened several NSCLC cell lines with gefitinib resistance by MTT assay and analysed the miR‐345/miR‐498 expression levels. NSCLC cells were pre‐treated with a resveratrol derivative, trans‐3,5,4‐trimethoxystilbene (TMS) and subsequently challenged with gefitinib treatment. The changes in apoptosis and miR‐345/miR‐498 expression were analysed by flow cytometry and q‐PCR respectively. The functions of miR‐345/miR‐498 were verified by CCK‐8 assay, cell cycle analysis, dual‐luciferase reporter gene assay and immunoblotting analysis. Our results showed that the expression of miR‐345 and miR‐498 significantly decreased in gefitinib resistant NSCLC cells. TMS pre‐treatment significantly upregulated the expression of miR‐345 and miR‐498 increasing the sensitivity of NSCLC cells to gefitinib and inducing apoptosis. MiR‐345 and miR‐498 were verified to inhibit proliferation by cell cycle arrest and regulate the MAPK/c‐Fos and AKT/Bcl‐2 signalling pathways by directly targeting MAPK1 and PIK3R1 respectively. The combination of TMS and gefitinib promoted apoptosis also by miR‐345 and miR‐498 targeting the MAPK/c‐Fos and AKT/Bcl‐2 signalling pathways. Our study demonstrated that TMS reduced gefitinib resistance in NSCLCs via suppression of the MAPK/Akt/Bcl‐2 pathway by upregulation of miR‐345/498. These findings would lay the theoretical basis for the future study of TMS for the treatment of EGFR‐TKI resistance in NSCLCs.     

同尾酶技术在构建疟疾多价重组DNA疫苗中的应用

同尾酶是一类识别不同核苷酸序列但能酶切产生相同粘性末端的限制性内切酶,依靠同尾酶的这种特性,可以根据需要将不同的ＤＮＡ 片段进行灵活组合,获得各种排列顺序的多价表位重组疫苗．将这种方法用于疟疾多价重组ＤＮＡ 疫苗的研制;ＢＡＬＢ／ｃ 小鼠免疫实验对所得重组疫苗ＰＵ２８６的免疫原性进行了测定．     

PNAS-4 expression and its relationship to p53 in colorectal cancer

PNAS-4 is a novel pro-apoptotic protein activated during the early response to DNA damage; however, the molecular mechanisms and pathways regulating PNAS-4 expression in tumors are not well understood. We hypothesized that PNAS-4 is a p53 down-stream target gene and designed this study. We searched online for putative p53-binding sites in the entire PNAS-4 gene and did not find any corresponding information. In HCT116 colon cancer cells, after being transfected with small interfering RNA to silence p53, the expressions of PNAS-4 and other known p53 target gene (Apaf1, Bax, Fas and Dr5) were determined by real-time PCR. We found that PNAS-4 was up-regulated while Apaf1, Bax, Fas and Dr5 were down-regulated. We then examined the expression of PNAS-4 and p53 mutation in colorectal cancer patients. PNAS-4 expressed both in colorectal cancers and normal tissues, but compared with paired control, PNAS-4 was up-regulated in cancers (P = 0.018). PNAS-4 overexpression ratios were correlated to the p53 mutant status (P = 0.001). The mean PNAS-4 expression levels of p53 mutant homozygote group and heterozygote group were higher than that of p53 wild type group (P = 0.013). The expression ratios of PNAS-4 (every sample in relative to its paired normal mucosa) were different between negative lymph node metastasis (66% up-regulated, 34% down-regulated) and positive metastasis (42% up-regulated, 58% down-regulated). Taken together, these findings suggested that PNAS-4 was not a p53 target, but overexpression of PNAS-4 was correlated to p53 inactivity in colorectal cancer.     

亚热带常绿树种对不同粒径颗粒物的滞留能力

可吸入颗粒物和细颗粒物是大部分城市的首要污染物,对人体健康和环境都有重要影响;而城市植物能吸附大气颗粒物,进而有效降低大气颗粒物浓度。为了深入探究不同树种叶表面特征与自身滞尘效益之间的关系,该研究以浙江省三种常见城市绿化树种(青冈、冬青、红花檵木)为对象,采用重量法提取各样本在3个粒径上(8~100,2.5~8,0.45~2.5μm)的单位叶面积滞尘量(μg·cm~(-2)),并结合叶面积指数估测全株滞尘量。结果表明:三种供试植物叶片对颗粒物平均单位叶面积滞留量在30.4~63.7μg·cm~(-2)之间,而平均单木滞尘量每株在1.36-9.36 g之间。红花檵木因其叶表粗糙、具有绒毛等特征,对颗粒物(0.45~100μm)有最大的吸附能力(63.74±12.0μg·cm~(-2));对于大颗粒物(8~100μm)和细颗粒物(0.45~2.5μm),三种植物叶片均对其分别具有最大(40.9%~57.5%)、最小(15.6%~20.6%)的吸附能力;对于单木滞尘量,青冈因其具有较大叶面积指数等特征,对颗粒物总吸附效果更佳(每株9.36g)。该研究结果表明城市绿化树种对减缓大气颗粒物污染起到重要作用。     

微生物角蛋白酶的分子生物学研究进展

角蛋白酶具有分解角蛋白的活性,在饲料,食品加工,环境废物处理等方面,具有广泛的应用前景。本文综述了微生物角蛋白酶的来源,角蛋白酶的理化性质,作用机理,基因分离和表达等分子生物学和基因工程研究进展,并对其应用前景进行了展望,对其今后的发展趋势进行了讨论。     

尾叶桉人工林生物量和生产力的研究

按径级标准木法测定了尾叶桉（Ｅｕｃａｌｙｐｔｕｓ ｕｒｏｐｈｙｌｌａ）器官生物量,建立了林木器官干重（ｗ）与胸径和树高（Ｄ＾３Ｈ）关系的相对生长方程,进而计算出尾叶桉林分的生物量和生产力。结果表明：东门林场１０年生尾叶桉人工林平均生物量为１４４．８５ｔ ｈｍ＾２,各器官生物量的在小序列为：干材（７１．６９％）〉根（１４．２１％）〉皮）７．９９％）〉枝（４．７１％）〉叶（４．７１％）〉叶（１．４０％     

茶园土壤的氮迁移特性

土壤氮素在降雨条件下淋失到深层土壤甚至进入地下水,不仅导致土壤肥力下降,同时还会造成地下水污染。本研究采用原状土柱室内模拟方法,通过模拟当地强降雨淋滤,研究了西双版纳州大渡岗普洱茶产区5年、20年、33年和56年茶园以及周边森林的0~20 cm和0~40 cm土壤层TN、NO_3~--N、NH_4~+-N和可溶性土壤有机氮(DON)的迁移变化,以及土壤p H变化对氮迁移的影响。结果表明:0~20 cm、0~40 cm土层的茶园土壤,TN迁移通量均随植茶年限的增加而增加(P0.05),茶园年龄每延长一年,通过20 cm深的土层向下迁移下渗的TN通量将增加235.13 mg·m~(-2),而通过40 cm深的土层TN迁移通量则增加151.24 mg·m~(-2);0~40 cm土层的NO_3~--N迁移通量与茶园植茶年限显著正相关(P0.05);0~20 cm土层的DON迁移通量与茶园植茶年限显著正相关(P0.05);而NH_4~+-N迁移量不随植茶年龄变化而变化(P0.05);茶园40 cm土层内的TN、DON和NH_4~+-N下渗迁移主要发生在0~20 cm,而NO_3~--N的迁移则主要发生在20~40 cm;40 cm土层的茶园土壤氮素以DON损失最多,其次为NO_3~--N,NH_4~+-N损失量最少;未发现茶园土壤p H对氮素迁移变化产生影响(P0.05)。     

罗格列酮对AD样小鼠学习记忆减退的影响及机制

研究了罗格列酮对链脲佐菌素(streptozotocin, STZ)脑室内注射的阿尔茨海默病(AD)模型小鼠学习记忆减退的影响及机制．在小鼠脑室内注射STZ建立AD模型,治疗组小鼠采用罗格列酮灌胃给药30天．Morris水迷宫实验检测小鼠学习记忆能力,免疫印迹和免疫荧光检测Tau蛋白的磷酸化、神经丝(NFs)蛋白的磷酸化及糖基化、JNK和ERK蛋白的表达,微管结合实验检测Tau蛋白与微管的组装功能,荧光染料Fluoro-Jade B检测小鼠脑内退变神经元．结果显示,相比对照组,模型组小鼠平均逃避潜伏期和路径长度明显增加、穿越隐匿平台次数明显减少、Tau和NFs蛋白表达过度磷酸化、NFs蛋白糖基化减弱,而用罗格列酮干预的小鼠学习记忆改善并且Tau和NFs蛋白的磷酸化水平降低、NFs蛋白糖基化水平增加,Tau蛋白与微管结合能力改善,模型组JNK的磷酸化高于对照组和治疗组、模型组ERK1的磷酸化低于对照组和治疗组、各组在ERK2磷酸化无明显差异,模型组小鼠脑中FJB标记的退化神经元明显多于对照组和治疗组．结果说明,罗格列酮能改善STZ脑室内注射引起的小鼠学习记忆减退,其机制可能与改善胰岛素信号通路、降低Tau和NFs蛋白的过度磷酸化、减少神经退行性变有关．     

副产物途径的缺失对大肠杆菌合成D-1,2,4-丁三醇的影响

【目的】敲除副产物途径,提高重组大肠杆菌D-1,2,4-丁三醇(D-1,2,4-Butanetriol,BT)产量。【方法】利用Red重组技术敲除木糖途径xyl AB基因及2-酮-3-脱氧木糖酸代谢途径的yag E及yjh H基因,考察其对重组菌生长、BT生产及副产物积累的影响。【结果】敲除xyl AB基因后,重组菌生物量降低57%,BT产量降低20%,单位菌体产量提高84%,木糖酸积累量提高52%。yag E或yjh H基因单独缺失重组菌生物量分别提高10%和5%,BT产量提高36%和14%。基因共同缺失后重组菌生物量降低了21%,BT产量提高184%,达到2.44 g/L,单位菌体产量提高258%。而共同敲除两途径,生物量降低了72%,虽然单位菌体产量提高了约4倍,但BT产量仅提高43%。p H调控下,重组菌木糖酸积累量下降,BT产量进一步提高,最高达3.11 g/L。【结论】xyl AB基因缺失后,虽有利于提高BT途径的效率,但由于木糖无法进入PPP途径及木糖酸积累,造成生物量降低,不利于BT合成。单独敲除yag E或yjh H后BT产量略有提高,而共同敲除这两基因更为有效地调整碳流向BT合成偏转。两途径共同敲除利于BT的合成,但由于菌体量的减少,无法大量获得BT。